GPN Vaccines: Funding, Investors & Team (Nov 2026)
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
GPN Vaccines has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in Nov 2026.
That round is below the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
GPN Vaccines Company Profile and Key Stats
Latest funding round on record: Nov 2026.
GPN Vaccines Funding Rounds
GPN Vaccines Investors
6 investors are recorded in total; the 5 named above are those the record identifies.
GPN Vaccines Founders and Leadership Team
Contact details for the GPN Vaccines team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →GPN Vaccines Funding Compared to Other Biotechnology Startups
GPN Vaccines' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like GPN Vaccines in Biotechnology and Adelaide
Companies Similar to GPN Vaccines
Kinoxis Therapeutics, an emerging biotechnology company located in Australia, is focused on advancing the…
AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…
The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication…
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…
Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…
Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…
Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…
Imugene is a publicly-listed biotechnology company with operations in America and Europe,
BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology
Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…
GPN Vaccines Funding FAQs
What does GPN Vaccines do?
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
How much funding has GPN Vaccines raised?
GPN Vaccines has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in Nov 2026.
When did GPN Vaccines last raise funding?
GPN Vaccines' most recent funding round on record is an undisclosed round of $7.0M, announced in Nov 2026.
Who has invested in GPN Vaccines?
Investors on record for GPN Vaccines include Forepont Capital Partners, Shearwater Capital, National Health and Medical Research Council, Government of South Australia, Kern Whelan Capital. FundedIQ records 6 investors in total.
Where is GPN Vaccines headquartered?
GPN Vaccines is based in Adelaide, Australia.
How many employees does GPN Vaccines have?
GPN Vaccines is in the 11-50 employee band.
When was GPN Vaccines founded?
GPN Vaccines was founded in 2017.
How does GPN Vaccines' funding compare to other Biotechnology startups?
GPN Vaccines' latest round of $7.0M is below the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's GPN Vaccines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GPN Vaccines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.